Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004;94:1562-1570
Published online before print May 6, 2004, doi: 10.1161/01.RES.0000131498.36194.6b
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
94/12/1562    most recent
01.RES.0000131498.36194.6bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prager, G. W.
Right arrow Articles by Binder, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prager, G. W.
Right arrow Articles by Binder, B. R.
Related Collections
Right arrow Angiogenesis
Right arrow Cell biology/structural biology
Right arrow Other Vascular biology
(Circulation Research. 2004;94:1562.)
© 2004 American Heart Association, Inc.


Molecular Medicine

Vascular Endothelial Growth Factor Receptor-2–Induced Initial Endothelial Cell Migration Depends on the Presence of the Urokinase Receptor

Gerald W. Prager*, Johannes M. Breuss*, Stefan Steurer, Damla Olcaydu, Judit Mihaly, Patrick M. Brunner, Hannes Stockinger, Bernd R. Binder

From the Department of Vascular Biology and Thrombosis Research (G.W.P., J.M.B., S.S., D.O., J.M., P.M.B., B.R.B.), University of Vienna; K-plus competence centre for Bio Molecular Therapeutics, BMT (J.M.B., H.S., B.R.B.); and the Institute of Immunology (H.S.), Vienna International Research Cooperation Center at Novartis Forschungs-Institut, University of Vienna, Vienna, Austria.

Correspondence to Bernd R. Binder, Department of Vascular Biology and Thrombosis Research University of Vienna, Schwarzspanierstr. 17, Vienna A-1090, Austria. E-mail bernd.binder{at}univie.ac.at

The angiogenic response of endothelial cells initiated by different growth factors is accompanied by assembly of cell surface–bound proteolytic machinery as a prerequisite for focal invasion. We have shown previously how the vascular endothelial growth factor (VEGF) initiates proteolysis by activation of pro-urokinase (pro-PA) via the VEGF receptor-2 (VEGFR-2). We now show that the cell surface receptor of the uPA-system, the urokinase receptor (uPAR), is redistributed to focal adhesions at the leading edge of endothelial cells in response to VEGF. VEGF165 and VEGF-E, both interacting with VEGFR-2, but not PlGF exclusively stimulating VEGFR-1, induce within minutes internalization of uPAR via an LDL receptor–like molecule, dependent on generation of active uPA and the presence of plasminogen activator inhibitor-1 (PAI-1). uPAR seems to play a pivotal role in VEGFR-2–induced endothelial cell migration because cleavage of surface uPAR impaired the migratory response of endothelial cells toward VEGF-E, but not toward PlGF.


Key Words: angiogenesis • VEGF • urokinase receptor




This article has been cited by other articles:


Home page
Cancer Res.Home page
Y. Jing, C. Tong, J. Zhang, T. Nakamura, I. Iankov, S. J. Russell, and J. R. Merchan
Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted against the Urokinase Receptor
Cancer Res., February 15, 2009; 69(4): 1459 - 1468.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. W. Prager, J. Mihaly, P. M. Brunner, Y. Koshelnick, G. Hoyer-Hansen, and B. R. Binder
Urokinase mediates endothelial cell survival via induction of the X-linked inhibitor of apoptosis protein
Blood, February 5, 2009; 113(6): 1383 - 1390.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
H. B. Schiller, A. Szekeres, B. R. Binder, H. Stockinger, and V. Leksa
Mannose 6-Phosphate/Insulin-like Growth Factor 2 Receptor Limits Cell Invasion by Controlling {alpha}V{beta}3 Integrin Expression and Proteolytic Processing of Urokinase-type Plasminogen Activator Receptor
Mol. Biol. Cell, February 1, 2009; 20(3): 745 - 756.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Y. Liu, D. J. Cao, I. M. Sainz, Y.-L. Guo, and R. W. Colman
The inhibitory effect of HKa in endothelial cell tube formation is mediated by disrupting the uPA-uPAR complex and inhibiting its signaling and internalization
Am J Physiol Cell Physiol, July 1, 2008; 295(1): C257 - C267.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. W.M. van Hinsbergh, M. A. Engelse, and P. H.A. Quax
Pericellular Proteases in Angiogenesis and Vasculogenesis
Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 716 - 728.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. W. Bauer, W. Liu, F. Fan, E. R. Camp, A. Yang, R. J. Somcio, C. D. Bucana, J. Callahan, G. C. Parry, D. B. Evans, et al.
Targeting of Urokinase Plasminogen Activator Receptor in Human Pancreatic Carcinoma Cells Inhibits c-Met- and Insulin-like Growth Factor-I Receptor-Mediated Migration and Invasion and Orthotopic Tumor Growth in Mice
Cancer Res., September 1, 2005; 65(17): 7775 - 7781.
[Abstract] [Full Text] [PDF]